NCT07655180Phase 3Completed

Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine

Study sponsor: Invivyd, Inc. · IVVD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-08-15Actual
Enrollment · participants210Actual
Source updated2026-10-14Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 4 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Completion date type changed

Before: Estimated. After: Actual.

Primary completion date changed

Before: Aug 2026. After: 15 Aug 2026.

Recruitment status changed

Before: Recruiting. After: Completed.

Check registry source